Consistency of the efficacy of cetirizine and ebastine on skin reactivity

Annals of Allergy, Asthma and Immunology

Volumn 80, Issue 1, 1998, Pages 61-65

  Frossard, Nelly ^a,b,d   Melac, Michel ^c   Benabdesselam, Ouardia ^a,b   Pauli, Gabrielle ^e  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UCB PHARMA   (Belgium)

^d INSERM   (France)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; EBASTINE; HISTAMINE;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL TRIAL; CONCENTRATION RESPONSE; CROSSOVER PROCEDURE; CUTANEOUS PARAMETERS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN MANIFESTATION; URTICARIA;

EID: 0031884144     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62941-9     Document Type: Article

References (25)

1. Juhlin L, Arendt C. Treatment of chronic urticaria with cetirizine dihydrochloride a non-sedating antihistamine. J Dermatol 1988;119:67-72.
2. Campoli-Richards DM, Buckley MMT, Fitton A. Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma and chronic urticaria. Drugs 1990;40:762-81.
3. Kietzmann H, Macher E, Rihoux JP, Ghys L. Comparison of cetirizine and terfenadine in the treatment of chronic idiopathic urticaria. Ann Allergy 1990; 65:498-500.
4. Peyri J, Vidai J, Marron J, et al. Ebastine in chronic urticaria: a double-blind placebo-controlled study. J Dermatol Treat 1991;2:51-3.
5. Hannuksela M, Kalimo K, Lammintausta K, et al. Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults. Ann Allergy 1993; 70:127-33.
6. Guerra L, Vincenzi C, Marchesi E, et al. Loratadine and cetirizine in the treatment of chronic urticaria. J Eur Acad Dermatol Vcncorol 1994;3: 148-52.
7. Spencer CM, Faulds D, Peters DH. Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs 1993;46:1055-80.
8. Kalis B. Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults. Drags 1996;52:30-4.
9. Wiseman LR, Faulds D. Ebastine: a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders. Drugs 1996; 51:260-77.
10. Ghys L, Rihoux JP. Pharmacological modulation of cutaneous reactivity to histamine: a double-blind acute comparative study between cetirizine, terfenadine and astemizole. J Inter Med Res 1989;17:24-7.
11. Simons FER, McMillan JLM, Simons KJ. A double blind, single-dose, cross-over comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced whcals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990;86:540-7.
12. Lobaton P, Moreno F, Coulie P. Comparison of cetirizine with astemizole in the treatment of perennial allergic rhinitis and study of the concomitant effect on histamine and allergen-induced wheal responses. Ann Allergy 1990; 65:401-5.
13. Rivest J, Despontin K, Ghys L, et al. Pharmacological modulation by cetirizine and ebastine of the cutaneous reactivity to histamine. Dermatologica 1991;183:208-11.
14. Charlesworth EN, Massey WA, Kagey-Sobotka A, et al. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge. J Pharmacol Exp Ther 1992; 262:964-70.
15. Nelson HS, Bucher B, Buchmeier A, et al. Suppression of the skin reaction to histamine by ebastine. Ann Allergy Asthma Immunol 1995;74:442-7.
16. Wood SG. The metabolism and pharmacokinetics of 14 C-cetirizine in humans. Ann Allergy 1987;59:31-4.
17. Bernheim J, Arendt C, de Vos C. Cetirizine: more than an antihistamine? Agents Actions Suppl 1991;34: 269-73.
18. Vincent J, Liminana R, Meredith PA, Reid JL. The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects. Br J Clin Pharmacol 1988;26: 497-502.
19. Yamaguchi T, Hashizume T, Matsuda M, et al. Pharmacokinetics of the H1-receptor antagonist ebastine and its aclive metabolite carebastine in healthy subjects. Arzneimittelforsch 1994;44: 59-64.
20. de la Cuadra J, Teruel M, Teixido P, Roma J. Assessment of the wheal size and skin blood flow of the erythema induced by histamine and its modification with cetirizine and ebastine: a cross-over, double-blind study. Dermatology 1994;188:131-4.
21. Coulie P, Ghys L, Rihoux JP. Inhibitory effects of orally or sublingually administered cetirizine on histamine-induced wheals, flares and their correlation with cetirizine plasma concentrations. J Intern Med Res 1991;19: 174-9.
22. Rihoux JP, Mariz S. Cetirizine. An updated review of its pharmacological properties and therapeutic efficacy. Clin Rev Allergy 1993;11:65-88.
23. Simons FER, Murray HE, Simons KJ. Quantitation of H1-receptor antagonists in skin and serum. J Allergy Clin Immunol 1995;95:759-64.
24. Simons FER. The antiallergic effects of antihistamines (H1-receptor antagonists). J Allergy Clin Immunol 1992; 90:705-15.
25. Gehanno P, Bremard-Oury C, Zeisser P. Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults. Ann Allergy Asthma Immunol 1996; 76:507-12.